These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6883389)

  • 1. Tumor markers of the central nervous system: biological basis and clinical relevance.
    Birkmayer GD
    Cancer Detect Prev; 1983; 6(1-2):317-24. PubMed ID: 6883389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor markers of the central nervous system.
    Birkmayer GD
    Cancer Detect Prev; 1981; 4(1-4):231-8. PubMed ID: 7349780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor antigens in astrocytic gliomas.
    Kurpad SN; Zhao XG; Wikstrand CJ; Batra SK; McLendon RE; Bigner DD
    Glia; 1995 Nov; 15(3):244-56. PubMed ID: 8586461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological aspects of experimental brain tumors (review).
    Stavrou D; Bilzer T; Hultén M; Zänker KS; Anzil AP; Haglid KG; Dahme E
    Anticancer Res; 1982; 2(3):151-5. PubMed ID: 6751209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination.
    Yu JS; Luptrawan A; Black KL; Liu G
    Clin Neurosurg; 2006; 53():345-51. PubMed ID: 17380773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-P53 antibodies in Brazilian brain tumor patients.
    Fonseca RF; Kawamura MT; Oliveira JA; Teixeira A; Alves G; Carvalho Mda G
    Genet Mol Res; 2003 Jun; 2(2):185-90. PubMed ID: 14966683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor markers: malignin and related recognins associated with malignancy rather than with cell type.
    Bogoch S; Bogoch ES
    Prog Clin Biol Res; 1980; 39():407-24. PubMed ID: 7403189
    [No Abstract]   [Full Text] [Related]  

  • 8. Surface antigens of human glioma cells shared with normal adult and fetal brain.
    Wikstrand CJ; Bigner DD
    Cancer Res; 1979 Aug; 39(8):3235-43. PubMed ID: 88260
    [No Abstract]   [Full Text] [Related]  

  • 9. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Immunological investigations on human brain tumor patients.
    Mahaley MS
    Proc Natl Cancer Conf; 1972; 7():811-5. PubMed ID: 4358071
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of local immunoresistance in glioma.
    Albesiano E; Han JE; Lim M
    Neurosurg Clin N Am; 2010 Jan; 21(1):17-29. PubMed ID: 19944963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor immune response: what are the roles for gliomas?].
    Dietrich PY
    Rev Neurol (Paris); 2001 Nov; 157(11 Pt 1):1339-48. PubMed ID: 11924003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
    Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN
    Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic sensitization to tumor-associated antigens during the growth of gliomas of the brain (experimental study)].
    Novichenko NL; Romodanov AP; Zhmareva EN; Gorovoĭ AI
    Zh Vopr Neirokhir Im N N Burdenko; 1984; (2):9-13. PubMed ID: 6741378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunogenic properties of human brain glioma antigens evaluated with rabbit sera by means of a complement fixation test].
    Rybarska I
    Neuropatol Pol; 1975; 13(2):183-94. PubMed ID: 167322
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-mediated cytotoxicity and serum-mediated blocking: evidence that their associated determinants on human tumor cells are different.
    Levy NL
    J Immunol; 1978 Sep; 121(3):916-22. PubMed ID: 80433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous serologic responses in glioma patients. Correlation with tumor grade and survival.
    Kornblith PL; Coakham HB; Pollock LA; Wood WC; Green SB; Smith BH
    Cancer; 1983 Dec; 52(12):2230-5. PubMed ID: 6640493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic analysis of nitrosourea-induced rat gliomas.
    Pfreundschuh M; Cravioto H; Hochwald G; Ransohoff J
    J Natl Cancer Inst; 1982 Mar; 68(3):501-5. PubMed ID: 6950179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion.
    Izumoto S; Ohnishi T; Arita N; Hiraga S; Taki T; Hayakawa T
    Cancer Res; 1996 Mar; 56(6):1440-4. PubMed ID: 8640837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibodies against human brain tumors].
    Yoshida J
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1706-14. PubMed ID: 6347088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.